Skip to main content

Fresenius Investment Highlights

More information about our strategy

CEO message

“We have made a solid start into 2022 – somewhat better, even, than expected at Fresenius Helios and Fresenius Kabi. The first quarter was burdened by the ongoing coronavirus pandemic, the war in Ukraine, supply chain bottlenecks and, above all, cost increases that are in some cases significant. We will have to watch all these factors very closely. Still, our businesses developed well.”


Stephan Sturm, Chairman of the Management Board 

Image Desc.

August 02, 2022
Bad Homburg, Germany

Conference Call Q2 2022, Fresenius

Next event

Non-financial and Sustainability Reporting

We are committed to responsible and sustainable management as part of our corporate culture and day-to-day business practice. Only by doing so can we be perceived as a trustworthy and reliable partner in the health care sector.

Share

Social Media

By clicking “I consent” you consent to the activation of the activity feed on this website and the following processing of your personal data related to it according to Section 2 of the Privacy Statement

News

Information & Order Service

Stay informed about the latest news and developments at our Group by subscribing to our Investor News and/or to the Fresenius Brief News. These services are free of charge and may be cancelled at any time.

Please send me via email
Fresenius Brief News
Fresenius Investor News
Do you have other questions or need any more information?
Please send us a message:
To unsubscribe to these services, please send a brief e-mail to ir-fre@fresenius.com or call +49 (0) 6172 608-2470.